Teva Pharmaceutical Industries Ltd (TEVA.N) Analysts | Reuters.com
Edition:
United States

Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

48.53USD
4:02pm EDT
Change (% chg)

$-1.48 (-2.96%)
Prev Close
$50.01
Open
$49.60
Day's High
$49.79
Day's Low
$48.01
Volume
1,311,974
Avg. Vol
1,107,004
52-wk High
$72.31
52-wk Low
$48.01

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.17 December 27 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 11 11 11 11
(2) OUTPERFORM 11 11 10 9
(3) HOLD 5 5 6 6
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.78 1.78 1.81 1.81

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 20 4,814.83 4,957.90 4,654.30 4,822.50
Quarter Ending Sep-16 17 6,367.94 6,587.00 5,982.00 4,742.50
Year Ending Dec-16 20 22,254.40 23,170.00 17,396.00 18,866.10
Year Ending Dec-17 22 25,075.80 26,896.90 19,757.00 19,104.60
Earnings (per share)
Quarter Ending Jun-16 21 1.17 1.22 1.02 1.29
Quarter Ending Sep-16 18 1.40 1.50 1.30 1.26
Year Ending Dec-16 21 5.26 5.51 5.09 5.13
Year Ending Dec-17 23 5.91 6.48 4.77 5.16
LT Growth Rate (%) 5 5.22 8.00 0.70 -0.12

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 4,769.13 4,810.00 40.87 0.86
Quarter Ending Sep-15 4,760.02 4,823.00 62.98 1.32
Quarter Ending Jun-15 4,910.32 4,966.00 55.68 1.13
Quarter Ending Mar-15 4,836.23 4,982.00 145.77 3.01
Quarter Ending Dec-14 5,157.17 5,168.00 10.83 0.21
Earnings (per share)
Quarter Ending Mar-16 1.16 1.20 0.04 3.06
Quarter Ending Sep-15 1.28 1.35 0.07 5.26
Quarter Ending Jun-15 1.31 1.43 0.12 8.85
Quarter Ending Mar-15 1.25 1.36 0.11 8.90
Quarter Ending Dec-14 1.31 1.31 0.00 0.15

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 4,814.83 4,814.83 4,814.13 5,311.14 4,822.50
Quarter Ending Sep-16 6,367.94 6,367.94 6,368.21 6,494.71 4,742.50
Year Ending Dec-16 22,254.40 22,254.40 22,268.90 22,751.90 18,866.10
Year Ending Dec-17 25,075.80 25,075.80 25,117.10 25,618.90 19,104.60
Earnings (per share)
Quarter Ending Jun-16 1.17 1.17 1.17 1.24 1.29
Quarter Ending Sep-16 1.40 1.39 1.39 1.45 1.26
Year Ending Dec-16 5.26 5.24 5.24 5.38 5.13
Year Ending Dec-17 5.91 5.86 5.88 6.06 5.16

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 2 0
Quarter Ending Sep-16 0 0 1 3
Year Ending Dec-16 0 0 1 4
Year Ending Dec-17 0 0 1 4
Earnings
Quarter Ending Jun-16 0 0 0 0
Quarter Ending Sep-16 0 0 1 1
Year Ending Dec-16 0 0 1 3
Year Ending Dec-17 0 0 1 4

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ – STARS Reports
$127.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.